- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02189460
Effect of Normal Aging on Language Processing (SEMVIE)
Cognitive Mechanisms and Cerebral Substrate of Naming Impairment During Aging. Behavior and Neuroimaging Approaches.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Grenoble, France, 38000
- IRMaGe facility
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
60 healthy adults will participate to the study. There will be 3 age groups: 30-50, 50-70, > 70 years. Ech group will contain 20 volunteers.
The volunteers are recruited by means of ads on Laboratory websites and Universities.
Description
Inclusion Criteria:
- Age of 30 years and above
- Right handed
- French native speakers
- Affiliation to French social security (Sécurité Sociale)
- Medical interview
- Consent form signed
Exclusion Criteria:
- Cerebral or respiratory pathologies
- Any MRI contrindication
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Healthy adults
20 young adults aged between 30 and 50 years old.
20 middle aged adults aged between 50 and 70 years old.
20 older adults of 70 years old and more.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood Oxygen Level Dependent functional MRI
Time Frame: There will be a unique MRI measurement for each participant. Group analyses presentation after 1 year.
|
We use 3 functional tasks using block paradigm: Object naming, Verbal generation and semantic judgment, to elicit BOLD response using fMRI in order to compare functional activation patterns between subjects. We also use hypercapnic challenge to elicit BOLD response in order to obtain Cerebral Vascular Reactivity properties of subjects. |
There will be a unique MRI measurement for each participant. Group analyses presentation after 1 year.
|
|
Anatomical MRI
Time Frame: There will be a unique MRI measurement for each participant. Group analyses presentation after 1 year.
|
We use Voxel Based Morphometry to compare cortical volume (grey matter) between subjects. We also use tractography Diffusion Tensor Imaging to compare white matter properties between subjects. |
There will be a unique MRI measurement for each participant. Group analyses presentation after 1 year.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Alexandre Krainik, Professor, Neuroradiology department, Grenoble Hospital, INSERM, Grenoble University.
- Study Director: Monica Baciu, Professor, Laboratory of Psychology and NeuroCognition, CNRS, Grenoble University.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2014-AZ00569-38
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognition
-
Westlake UniversityThe Third People's Hospital of Hangzhou; Affiliated Hangzhou First People's...Not yet recruiting
-
Huashan HospitalChinese Academy of SciencesRecruiting
-
RenJi HospitalShanghai Jiao Tong University School of MedicineRecruiting
-
Eunice Kennedy Shriver National Institute of Child...National Institutes of Health Clinical Center (CC); United States Department... and other collaboratorsCompletedCognitionUnited States
-
University of MinnesotaUniversity of California, San Francisco; Posit Science CorporationCompleted
-
GlaxoSmithKlineCompleted
-
Newcastle UniversityCompleted
-
GlaxoSmithKlineCambridge Cognition LtdCompleted
-
University of LeedsWelch's, Inc.Completed
-
Maastricht University Medical CenterCompleted